Autres langues Zimmer Biomet Holdings, Inc. Swiss Exchange

Actions

ZBH

US98956P1021

Marché Fermé - Swiss Exchange Autres places de cotation 09:17:28 24/04/2024			Varia. 5j.	Varia. 1 janv.
113 ^CHF	+15,31%		-.--%	+15,31%

04/06	Un initié de Zimmer Biomet Holdings a vendu des actions pour une valeur de 1 474 582 $, selon un récent dépôt auprès de la SEC	MT
31/05	L'exposition limitée de Zimmer Biomet aux marchés à forte croissance suscite des inquiétudes quant aux revenus, selon UBS	MT

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Osteal Therapeutics, Inc. announced that it has received $50 million in funding from Zimmer Biomet Holdings, Inc., Johnson & Johnson Innovation - JJDC, Inc., HM Capital Management, LLC, GIDEON STRATEGIC PARTNERS LLC and other investors	05/06
Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	04/06
Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference	04/06
Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says	31/05
EE.UU. - Valores a seguir en Wall Street (actualizado)	31/05
Zimmer Biomet Outlines Growth Strategy Through 2027; Board Approves $2 Billion Stock Buyback	29/05
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day	29/05
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $2,000 million worth of its shares.	29/05
Zimmer Biomet Holdings, Inc. authorizes a Buyback Plan.	29/05
Deepull appoints Didier Deltort to its Board of Directors	23/05
Osteal Therapeutics, Inc. announced that it expects to receive funding	22/05
Zimmer Biomet Announces 2024 Investor Day	20/05
4 Stocks to Watch in the Booming Regenerative Medicine Market	20/05
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024	13/05
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024	13/05
Zimmer Biomet Publishes 2023 Sustainability Report	06/05
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	02/05
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated	02/05
(ZBH) ZIMMER BIOMET HOLDINGS Expects Fiscal Year 2024 EPS Range $8.00 - $8.15	02/05
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Reports Q1 Revenue $1.89B, vs. Street Est of $1.87B	02/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zimmer Biomet Holdings, Inc. Swiss Exchange

Actions

ZBH

US98956P1021

Autres langues

Filtres